English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 92664/122999 (75%)
Visitors : 26919651      Online Users : 594
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    政大機構典藏 > 理學院 > 心理學系 > 期刊論文 >  Item 140.119/19979
    Please use this identifier to cite or link to this item: http://nccur.lib.nccu.edu.tw/handle/140.119/19979

    Title: A possible correlation between oxytocin-induced and angiotensin IV-induced anti-hyperalgesia at the spinal level in rats
    Authors: Chow, Lok-Hi;Tao, Pao-Luh;Chen, Jin-Chun;Liao, Ruey-Ming;Chang, En-Pei;Huang, Eagle Yi-Kung;廖瑞銘
    Contributors: 國立政治大學心理學系
    Keywords: Oxytocin;Angiotensin IV;Insulin-regulated aminopeptidase (IRAP);Hyperalgesia;Carrageenan;Spinal cord
    Date: 2013
    Issue Date: 2008-12-29 15:43:54 (UTC+8)
    Abstract: In our previous study, we showed that intrathecal (i.t.) administration of angiotensin IV (Ang IV), an insulin-regulated aminopeptidase (IRAP) inhibitor, attenuated inflammatory hyperalgesia in rats. Using the plantar test in rats with carrageenan-induced paw inflammation, we investigated the possible mechanism(s) of this effect. Because i.t. oxytocin was reported to produce a dose-dependent anti-hyperalgesia in rats with inflammation, we speculate that there is a possible correlation between oxytocin-induced and Ang IV-induced anti-hyperalgesia. Using i.t. co-administered atosiban (oxytocin receptor antagonist), the anti-hyperalgesia by Ang IV was completely abolished. This indicated that oxytocin could be the major IRAP substrate responsible for the anti-hyperalgesia by Ang IV. When Ang IV was co-administered with a low dose of oxytocin, there was a significant enhancing effect of Ang IV on oxytocin-induced anti-hyperalgesia. In recent reports, electrical stimulation on the paraventricular hypothalamic nucleus (PVN) was proved to increase oxytocin release at the spinal cord. Our results also showed that Ang IV could prolong the anti-hyperalgesia induced by PVN stimulation. This suggests a possible protective effect of Ang IV on endogenous oxytocin degradation/dysfunctioning. Moreover, we examined the local effect of intraplantarly injected Ang IV in the same model. Our results showed no effect of local Ang IV on hyperalgesia and paw edema, indicating that Ang IV may not regulate the peripheral inflammatory process. Overall, our study suggests that Ang IV may act through the inhibition of the activity of IRAP to reduce the degradation of oxytocin at the spinal cord, thereby leading to anti-hyperalgesia in rats with inflammation.
    Relation: Peptides, 39(1), 21-28
    Data Type: article
    DOI 連結: http://dx.doi.org/10.1016/j.peptides.2012.10.012
    DOI: 10.1016/j.peptides.2012.10.012
    Appears in Collections:[心理學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    liao01.pdf381KbAdobe PDF1071View/Open

    All items in 政大典藏 are protected by copyright, with all rights reserved.

    社群 sharing

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback